Ligand Pharmaceuticals Incorporated (LGND) Insider Trading
- $5,095,853.39
- $210,833,691.85
- March 5, 2024
- John L Higgins
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 5, 2024 | Director | 1,893 | $74.30 | Sell | $140,649.90 | |
Feb. 28, 2024 | CFO | 140 | $88.46 | Sell | $12,384.40 | |
Sept. 22, 2023 | CEO | 4,000 | $59.38 | Buy | $237,520.00 | |
May 16, 2023 | Director | 4,444 | $77.20 | Sell | $343,076.80 | |
May 10, 2023 | Director | 6,408 | $77.13 | Sell | $494,249.04 | |
May 8, 2023 | Director | 6,408 | $76.56 | Sell | $490,596.48 | |
March 24, 2023 | Insider | 300 | $69.92 | Sell | $20,976.00 | |
Dec. 16, 2022 | Director | 10,000 | $61.87 | Sell | $618,700.00 | |
Nov. 17, 2022 | CEO | 10,000 | $78.32 | Sell | $783,200.00 | |
Nov. 9, 2022 | CFO | 1,696 | $75.64 | Sell | $128,285.44 | |
Sept. 15, 2022 | CEO | 2,000 | $90.00 | Sell | $180,000.00 | |
May 13, 2022 | COO | 2,500 | $82.76 | Buy | $206,900.00 | |
Feb. 28, 2022 | Director | 908 | $102.62 | Sell | $93,178.96 | |
Nov. 12, 2021 | CEO | 3,000 | $160.50 | Sell | $481,500.00 | |
Nov. 11, 2021 | COO | 11,160 | $163.02 | Sell | $1,819,303.20 | |
Aug. 4, 2021 | COO | 8,840 | $109.67 | Sell | $969,482.80 | |
Feb. 10, 2021 | Director | 5,083 | $213.14 | Sell | $1,083,390.62 | |
Feb. 4, 2021 | SVP | 18,097 | $178.50 | Sell | $3,230,314.50 | |
Feb. 4, 2021 | COO | 44,547 | $176.86 | Sell | $7,878,582.42 | |
Jan. 27, 2021 | CEO | 40,000 | $182.00 | Sell | $7,280,000.00 | |
Jan. 25, 2021 | CEO | 50,000 | $159.00 | Sell | $7,950,000.00 | |
Aug. 24, 2020 | COO | 78 | $110.89 | Sell | $8,649.42 | |
Aug. 21, 2020 | COO | 7,225 | $112.88 | Sell | $815,558.00 | |
June 4, 2020 | SVP | 11,146 | $118.59 | Sell | $1,321,804.14 | |
Feb. 27, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 | |
Feb. 27, 2020 | COO | 1,706 | $21.92 | Buy | $37,395.52 | |
Feb. 27, 2020 | COO | 7,225 | $110.00 | Sell | $794,750.00 | |
Feb. 15, 2020 | COO | 869 | $97.23 | Sell | $84,492.87 | |
Feb. 15, 2020 | COO | 447 | $97.23 | Sell | $43,461.81 | |
Feb. 15, 2020 | COO | 1,170 | $97.23 | Sell | $113,759.10 | |
Feb. 14, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 | |
Feb. 14, 2020 | COO | 7,225 | $95.84 | Sell | $692,444.00 | |
Feb. 13, 2020 | COO | 496 | $21.92 | Buy | $10,872.32 | |
Feb. 13, 2020 | COO | 7,396 | $0.00 | Buy | $0.00 | |
Sept. 3, 2019 | Director | 750 | $87.01 | Buy | $65,257.50 | |
Aug. 5, 2019 | Director | 746 | $90.01 | Buy | $67,147.46 | |
Aug. 2, 2019 | Director | 1,000 | $95.98 | Buy | $95,980.00 | |
July 31, 2019 | CEO | 1,850 | $95.45 | Buy | $176,582.50 | |
July 31, 2019 | Director | 4,004 | $99.22 | Buy | $397,276.88 | |
July 29, 2019 | Director | 250 | $106.01 | Buy | $26,502.50 | |
June 11, 2019 | Director | 250 | $107.01 | Buy | $26,752.50 | |
May 31, 2019 | Director | 1,000 | $109.51 | Buy | $109,510.00 | |
May 29, 2019 | Director | 250 | $111.01 | Buy | $27,752.50 | |
May 20, 2019 | Director | 250 | $112.01 | Buy | $28,002.50 | |
May 14, 2019 | CEO | 2,500 | $113.50 | Buy | $283,750.00 | |
May 14, 2019 | Director | 250 | $112.51 | Buy | $28,127.50 | |
March 13, 2019 | CEO | 2,500 | $114.29 | Buy | $285,725.00 | |
March 13, 2019 | Director | 202 | $112.51 | Buy | $22,727.02 | |
Oct. 8, 2018 | Director | 2,500 | $253.99 | Sell | $634,975.00 | |
Oct. 1, 2018 | COO | 12,000 | $273.88 | Sell | $3,286,560.00 |
Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.
The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Charles S Berkman, Todd C Davis, Bvf Partners L P/Il, Stephen L Sabba, Melanie J Herman, David M Knott, Bvf Partners P/Il, John L Lamattina, David Knott, Nishan M Desilva, Sunil Patel, John Sharp, Charles Berkman, Matthew E Korenberg, Matthew Foehr, Octavio Espinoza, Todd Davis, John Higgins, John Lamattina, John W. Kozarich, Melanie J. Herman, and Andrew Reardon
The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.
Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.
Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.
The most recent insider trade for Ligand Pharmaceuticals Incorporated was on March 5, 2024.
The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Bvf Partners L P/Il with a total value of $898,794.00 on Dec. 6, 2012.
The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.